Percheron Therapeutics Ltd
ASX:PER

Watchlist Manager
Percheron Therapeutics Ltd Logo
Percheron Therapeutics Ltd
ASX:PER
Watchlist
Price: 0.074 AUD Market Closed
Market Cap: 76.7m AUD
Have any thoughts about
Percheron Therapeutics Ltd?
Write Note

Wall Street
Price Targets

PER Price Targets Summary
Percheron Therapeutics Ltd

Wall Street analysts forecast PER stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for PER is 0.218 AUD with a low forecast of 0.152 AUD and a high forecast of 0.263 AUD.

Lowest
Price Target
0.152 AUD
105% Upside
Average
Price Target
0.218 AUD
194% Upside
Highest
Price Target
0.263 AUD
255% Upside
Percheron Therapeutics Ltd Competitors:
Price Targets
000423
Dong-E-E-Jiao Co Ltd
35% Upside
002422
Sichuan Kelun Pharmaceutical Co Ltd
41% Upside
MARKSANS
Marksans Pharma Ltd
6% Downside
NEULANDLAB
Neuland Laboratories Ltd
21% Upside
300558
Betta Pharmaceuticals Co Ltd
5% Upside
AXSM
Axsome Therapeutics Inc
32% Upside
002728
Teyi Pharmaceutical Group Co Ltd
63% Upside
086450
Dongkook Pharmaceutical Co Ltd
49% Upside

Revenue
Forecast

Revenue Estimate
Percheron Therapeutics Ltd

For the last 8 years the compound annual growth rate for Percheron Therapeutics Ltd's revenue is -7%. The projected CAGR for the next 3 years is 161%.

-7%
Past Growth
161%
Estimated Growth
Estimates Accuracy
-81%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Percheron Therapeutics Ltd

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
8%
Average Beat

Net Income
Forecast

Net Income Estimate
Percheron Therapeutics Ltd

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-40%
Average Miss

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is PER's stock price target?
Price Target
0.218 AUD

According to Wall Street analysts, the average 1-year price target for PER is 0.218 AUD with a low forecast of 0.152 AUD and a high forecast of 0.263 AUD.

What is Percheron Therapeutics Ltd's Revenue forecast?
Projected CAGR
161%

For the last 8 years the compound annual growth rate for Percheron Therapeutics Ltd's revenue is -7%. The projected CAGR for the next 3 years is 161%.

Back to Top